Companies
Description
ASKA Pharmaceutical is a Japanese pharmaceutical company founded in 1920. The company focuses on the research, development, and production of pharmaceutical products, particularly in the areas of cardiovascular diseases, central nervous system disorders, and hematology. They have a range of drugs targeting various diseases including hypertension, thrombosis, and psychiatric disorders. ASKA Pharmaceutical is committed to advancing scientific knowledge and improving the treatment options available for patients in need.
Drugs of ASKA Pharmaceutical
Description
AbbVie is a pharmaceutical company that was founded in 2013 as a spin-off from Abbott Laboratories. The company focuses on the development of drugs for a range of therapeutic areas, including immunology, oncology, neuroscience, and virology. Some of their notable drugs include Humira (adalimumab) for rheumatoid arthritis and other autoimmune diseases, as well as Imbruvica (ibrutinib) for certain types of leukemia. They are known for their innovative research and development efforts in these areas.
Description
Abbott Laboratories is a global healthcare company that focuses on developing and manufacturing pharmaceuticals, medical devices, and nutritional products. The company was founded in 1888 and has a strong focus on a wide range of therapeutic areas, including cardiovascular, diabetes, immunology, oncology, and neuroscience. Abbott's pharmaceutical portfolio includes drugs for the treatment of various diseases, such as heart diseases, infectious diseases, autoimmune disorders, and cancer. The company is known for its innovative products and for its commitment to advancing medical science and improving patient outcomes.
Description
Actelion, a pharma company with a focus on pulmonary arterial hypertension (PAH) and other rare diseases, was founded in 1997. Their notable drug, Tracleer (bosentan), was among the first PAH-specific therapies. Additionally, they have developed Opsumit and Uptravi for the treatment of PAH. With a strong emphasis on research and development, Actelion's commitment to addressing unmet medical needs has been recognized in the scientific community.
Description
Aegerion Pharmaceuticals is a biopharmaceutical company that specializes in developing and commercializing innovative therapies for patients with rare diseases. The company was founded in 2005 and has a focus on developing treatments for rare genetic lipid disorders, including homozygous familial hypercholesterolemia (HoFH) and familial chylomicronemia syndrome (FCS). Aegerion has developed drugs such as lomitapide (Juxtapid) for the treatment of HoFH and has been involved in research and development for other rare diseases related to lipid metabolism.
Drugs of Aegerion Pharmaceuticals
Description
Ajinomoto is a global pharmaceutical company that specializes in the development and production of a wide range of pharmaceutical products. They focus on areas such as metabolic diseases, neurological disorders, oncology, and immunology. They have a strong emphasis on research and development, aiming to provide innovative treatments for various diseases. The company was founded in 1909 and has since grown to become a leader in the pharmaceutical industry.
Drugs of Ajinomoto
Description
Alexion is a global biopharmaceutical company that focuses on developing and delivering life-transforming therapies for patients with severe and rare diseases. The company was founded in 1992 and is known for its development of innovative monoclonal antibody drugs. One of their most well-known drugs is Soliris (eculizumab), which is used to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Alexion also focuses on developing therapies for other rare and devastating diseases, such as generalized myasthenia gravis and neuromyelitis optica spectrum disorder.
Description
Alfresa Pharma is a Japanese pharmaceutical company focusing on the development and production of a wide range of pharmaceutical products. The company was established in 2000 and has been involved in the research and development of drugs to treat various diseases and conditions including cardiovascular diseases, diabetes, and cancer. Alfresa Pharma's primary focus lies in providing high-quality and innovative pharmaceutical products to contribute to the improvement of healthcare.
Drugs of Alfresa Pharma
Description
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi) therapeutics for the treatment of rare genetic, cardio-metabolic, and hepatic infectious diseases. The company was founded in 2002 and has since focused on advancing RNAi-based drugs to address unmet medical needs. Alnylam has several drugs in various stages of development, targeting diseases such as hereditary amyloidosis, acute hepatic porphyrias, and primary hyperoxaluria. They are known for their innovative work in utilizing RNAi technology to silence disease-causing genes and have garnered attention for their potential to revolutionize the treatment of genetic disorders.
Description
The company Amersham, also known as Amersham plc, was a global company specializing in life sciences. They were known for their work in medical imaging and pharmaceutical diagnostics. Amersham developed a range of products and technologies for medical research, drug discovery, and diagnostics, including radiopharmaceuticals used in nuclear medicine. They were a leading company in the development of imaging agents for various diagnostic procedures. The company was founded in 1946 and became part of GE Healthcare in 2004.
Drugs of Amersham
Description
Amgen is a biotechnology company that specializes in the development of innovative medicines to treat serious illnesses. Founded in 1980, Amgen has made significant contributions to biopharmaceutical research, particularly in the fields of oncology, nephrology, and inflammatory diseases. The company has developed a wide range of drugs, including those for treating cancer, bone health, and autoimmune diseases. Their products often target specific biological pathways to address unmet medical needs in a variety of conditions.
Description
Amicus Therapeutics is a biotechnology company that focuses on developing innovative treatments for rare and orphan diseases, particularly genetic disorders such as Fabry disease and Pompe disease. The company was founded in 2002 and has since been a pioneer in the development of therapies based on genetically defined diseases. Their focus on chaperone-advanced replacement therapy (CHART) platform has resulted in the development of enzyme replacement therapies and pharmacological chaperones designed to target specific protein misfolding or instability. Overall, Amicus Therapeutics is dedicated to advancing precision medicine solutions for a range of rare genetic diseases.
Drugs of Amicus Therapeutics
Description
AnGes is a Japanese pharmaceutical company that was founded in 1999. The company focuses on the research and development of gene therapy-based drugs for the treatment of various diseases, including cancer, cardiovascular diseases, and genetic disorders. AnGes is known for its innovative work in the field of gene therapy, particularly in the development of therapeutic DNA vaccines and gene delivery technologies. Some of their notable drugs include HGF plasmid, which targets peripheral arterial disease, and BRITE, a DNA vaccine for cancer immunotherapy.
Drugs of AnGes
Description
Asahi Kasei Pharma is a pharmaceutical company that focuses on the development of innovative and effective drugs for the treatment of various diseases and medical conditions. Founded in 1971, the company has a strong focus on research and development in therapeutic areas such as cardiovascular diseases, metabolic disorders, and central nervous system disorders. Their portfolio includes a range of pharmaceutical products aimed at providing solutions for patients suffering from conditions like hypertension, diabetes, and psychiatric disorders. Asahi Kasei Pharma is dedicated to advancing medical science and improving patient care through their innovative drug development efforts.
Drugs of Asahi Kasei Pharma
Description
Astellas Pharma is a global pharmaceutical company with a focus on advancing the field of pharmaceutical research and development. The company is known for its innovative drugs and treatments for various medical conditions, including urology, oncology, immunology, and infectious diseases. Astellas Pharma has a history of developing medications for conditions such as overactive bladder, prostate cancer, transplant rejection, and fungal infections. Founded in 2005 through the merger of two Japanese pharmaceutical companies, Astellas has since expanded its operations to become a well-respected leader in the healthcare industry.
Description
AstraZeneca is a pharmaceutical company that focuses on developing and commercializing innovative drugs for the treatment of a wide range of diseases. They work in areas such as oncology, cardiovascular, renal and metabolism, and respiratory diseases. Some of their notable drugs include Tagrisso for lung cancer, Brilinta for heart disease, and Farxiga for diabetes. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC.
Description
Baxter is a global pharmaceutical company that was founded in 1931. They have a strong focus on providing innovative medical products, including pharmaceuticals, biologicals, and medical devices. Baxter's product portfolio includes treatments for a wide range of diseases and medical conditions, including hemophilia, immune deficiencies, and kidney disease. They are known for their expertise in developing therapies for patients with complex healthcare needs.
Description
Bayer, founded in 1863, is a multinational pharmaceutical and life sciences company with a focus on developing drugs for a wide range of therapeutic areas including cardiology, oncology, hematology, women's healthcare, and ophthalmology. They are known for developing innovative drugs to treat various diseases such as cancer, cardiovascular diseases, diabetes, and infectious diseases. Some of their well-known products include Xarelto (rivaroxaban), a blood thinner, and Nexavar (sorafenib), a cancer medication.
Description
I couldn't find specific information about "BioMarin Pharmaceutical Japan." However, BioMarin Pharmaceutical is a global biotechnology company with a focus on developing and commercializing innovative therapies for patients with rare genetic diseases. The company's portfolio includes drugs for rare genetic disorders such as phenylketonuria (PKU), Batten disease, hemophilia, and various forms of inherited metabolic disorders. BioMarin has been a leader in the development of enzyme replacement and gene therapy treatments for these conditions. The company was founded in 1997 and continues to invest in research and development to address the unmet medical needs of individuals with rare diseases.
Description
Biogen is a global biotechnology company that focuses on the development of therapies for neurological disorders, autoimmune diseases, and rare genetic conditions. The company was founded in 1978 and has since become known for its research and development in the field of neuroscience. Biogen's drug portfolio includes treatments for multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. The company's innovative therapies aim to address the underlying mechanisms of these diseases and improve patient outcomes.
Drugs of Bipha
Description
Boehringer Ingelheim is a pharmaceutical company that was founded in 1885. It focuses on developing medications for a range of diseases including respiratory, cardiovascular, immune system, and central nervous system disorders. The company's drugs include treatments for conditions such as pulmonary fibrosis, diabetes, stroke prevention, and epilepsy. Boehringer Ingelheim has a reputation for its research and development efforts in innovative drug discovery and therapy improvement.
Description
Bristol Myers Squibb is a pharmaceutical company known for its work in oncology, cardiovascular and immunology therapeutics. The company was founded in 1887 and has developed a range of drugs to treat cancer, HIV/AIDS, cardiovascular diseases, and other chronic conditions. Some of their well-known drugs include Opdivo (nivolumab) for cancer immunotherapy and Eliquis (apixaban) for preventing blood clots and stroke in patients with atrial fibrillation. They have also worked on therapies for autoimmune diseases and have a long history of research and development in the pharmaceutical industry.
Description
CSL Behring is a global biotechnology company with a focus on developing and manufacturing innovative biopharmaceuticals for the treatment of rare and serious diseases. The company specializes in the production of plasma-derived and recombinant therapies, particularly in the areas of immunology, neurology, and hematology. Founded in 1916, CSL Behring has a long history of expertise in the field of blood plasma fractionation and has developed a range of therapies for conditions such as hemophilia, primary immune deficiencies, and autoimmune diseases.
Description
Central Glass is a pharmaceutical company that was established in 1934 with a focus on developing and manufacturing pharmaceuticals, as well as various other chemicals and materials. They have been involved in the development of drugs for various therapeutic areas, including cardiovascular diseases, central nervous system disorders, and oncology. They have also been involved in the treatment of diabetes and various rare diseases. Additionally, Central Glass has been active in creating innovative drug delivery systems and materials for medical devices.
Drugs of Central Glass
Description
The Chemo-Sero-Therapeutic Research Institute, also known as Kaketsuken, is a Japanese pharmaceutical company. It was founded in 1949 and primarily focuses on the research and development of vaccines and therapeutic agents for infectious diseases. The company has a strong emphasis on biotechnology and has contributed to the development of vaccines for diseases such as hepatitis and influenza. Additionally, it has been involved in the research and production of diagnostic reagents.
Drugs of Chemo-Sero-Therapeutic Research Institute
Description
Chugai Pharmaceutical Co., Ltd. is a pharmaceutical company based in Japan and is a member of the Roche Group. The company was founded in 1925 and has a focus on the research and development of innovative pharmaceutical products, particularly in the areas of oncology, immunology, and other specialized therapeutic areas. Chugai has developed drugs for the treatment of various diseases such as cancer, rheumatoid arthritis, and other autoimmune disorders. Their commitment to scientific innovation and collaboration with Roche positions them as a leading player in the global pharmaceutical industry.
Description
Clinigen is a global pharmaceutical and services company that specializes in providing access to critical, life-saving medicines and clinical trial services. Founded in 2007, the company's primary focus is on the development and supply of niche and critical care medicines to address unmet medical needs in areas such as oncology, HIV, infectious diseases, and rare diseases. Clinigen also provides access to licensed and unlicensed medicines for patients and healthcare professionals and supports clinical trial supply and management.
Drugs of Clinigen
Description
Daiichi Sankyo is a pharmaceutical company that focuses on the development and distribution of innovative drugs. They have a strong presence in cardiovascular and metabolic disease treatment, as well as oncology. Founded in 2005 through the merger of two leading Japanese pharmaceutical companies, Daiichi Sankyo has since expanded its global reach and continues to advance treatments for a variety of diseases.
Drugs of Daiichi Sankyo
Description
Daiichi Sankyo Pharma is a pharmaceutical company that was founded in 2005. They focus on research and development of drugs for various diseases including cardiovascular diseases, cancer, and metabolic disorders. Their portfolio includes medications such as blood pressure-lowering drugs and antiplatelet agents. They have a strong emphasis on innovation and are dedicated to advancing medical science to improve patient outcomes.
Drugs of Daiichi Suntory Pharma
Drugs of Dojin Iyaku-Kako
Description
EA Pharma is a pharmaceutical company that focuses on the development and commercialization of drugs for gastrointestinal diseases and other gastrointestinal-related conditions. Founded in 2016, the company prioritizes research and development in the field of gastroenterology, with a focus on addressing unmet medical needs in this therapeutic area. Their portfolio may include medications for conditions such as inflammatory bowel disease, irritable bowel syndrome, and gastrointestinal cancers.
Drugs of EA Pharma
Description
Eiken Chemical is a Japanese pharmaceutical company specializing in the development and manufacturing of in vitro diagnostics, molecular biology reagents, and clinical testing systems. Founded in 1939, the company focuses on diagnostic products for infectious diseases, genetic testing, and various other medical applications. Their innovative products contribute to the diagnosis and treatment of a wide range of diseases, including viral infections, cancer, and genetic disorders.
Drugs of Eiken Chemical
Description
Eisai is a pharmaceutical company founded in 1941 and headquartered in Japan. They focus on developing innovative drugs for neurological and oncological diseases. Their portfolio includes treatments for Alzheimer's disease, epilepsy, and various types of cancer. Eisai is known for its commitment to research and development in the field of neuroscience and its dedication to improving the quality of life for patients with neurological disorders.
Drugs of Eisai
Description
Eli Lilly, a pharmaceutical company founded in 1876, focuses on developing and manufacturing a wide range of pharmaceutical products to treat various medical conditions such as diabetes, neurodegenerative diseases, cancer, and autoimmune disorders. Some of their key drugs include insulin products for diabetes management, antidepressants, and cancer treatments. They also specialize in developing biotechnology-based therapies and medications aimed at improving patient outcomes.
Description
FUJIFILM Toyama Chemical Co., Ltd. is a pharmaceutical company that focuses on the research, development, and commercialization of innovative drugs. Their research and development activities are primarily focused on therapeutic areas such as oncology, central nervous system disorders, infectious diseases, and allergies. The company has a strong commitment to discovering and developing new drugs to address unmet medical needs and improve patient outcomes. Founded in 1940, the company has a long history of contributing to the pharmaceutical industry through the development of innovative drugs for various diseases.
Drugs of FUJIFILM Toyama Chemical
Description
Ferring Pharmaceuticals is a global biopharmaceutical company with a focus on reproductive medicine, women's health, urology, and gastroenterology. Founded in 1950, the company has developed a range of innovative drugs and treatments for conditions such as infertility, endometriosis, prostate cancer, and gastrointestinal disorders. Ferring's research and development efforts are dedicated to advancing solutions for patients in these particular therapeutic areas.
Drugs of Ferring Pharmaceuticals
Description
Fresenius is a pharmaceutical company that focuses on developing and manufacturing drugs and medical devices for a variety of therapeutic areas, including renal and critical care, infusion therapy, and oncology. The company was founded in 1912 and has since expanded its portfolio to include a range of pharmaceutical products for treating conditions such as chronic kidney disease, cancer, and infectious diseases. Fresenius is known for its expertise in renal therapeutics and has made significant contributions to the field of nephrology.
Drugs of Fresenius
Drugs of Fujiyakuhin
Description
GE Healthcare is a leading global pharmaceutical company that focuses on developing innovative medical solutions to improve the diagnosis and treatment of diseases. The company offers a wide range of pharmaceutical products and medical devices across various therapeutic areas, including oncology, cardiology, neurology, and medical imaging. Founded in 1994, GE Healthcare has made significant contributions to the advancement of medical technology and has played a crucial role in the development of diagnostic tools and drug therapies for a variety of diseases.
Drugs of GE Healthcare
Description
GSK, also known as GlaxoSmithKline, is a global pharmaceutical company that focuses on the research, development, and production of innovative medicines, vaccines, and consumer healthcare products. Founded in 2000 through the merger of GlaxoWellcome and SmithKline Beecham, GSK has a strong presence in various therapeutic areas including respiratory, HIV, oncology, and rare diseases. The company's diverse portfolio includes drugs for treating conditions such as asthma, COPD, HIV, cancer, and vaccines for infectious diseases. GSK is also known for its commitment to addressing global health challenges and has a focus on developing sustainable healthcare solutions.
Drugs of GSK
Description
Galderma is a pharmaceutical company that specializes in dermatology. It was founded in 1981 as a joint venture between Nestlé and L'Oréal. The company focuses on developing and manufacturing drugs and products for the treatment of various skin conditions, including acne, psoriasis, rosacea, skin aging, and skin cancer. Galderma is known for its innovative research and development in the field of dermatology. Some of its well-known products include Epiduo, Cetaphil, and Oracea, among others.
Drugs of Galderma
Description
Gilead Sciences is a pharmaceutical company founded in 1987 and specializes in the development of therapeutics for life-threatening diseases. Its focus areas include antiviral drugs, such as those for HIV/AIDS and hepatitis, as well as treatments for other infectious diseases. Gilead Sciences has also expanded into the development of drugs for cardiovascular, respiratory, and other chronic conditions. Notable products include Truvada, Atripla, and Remdesivir.
Description
GlaxoSmithKline is a pharmaceutical company founded in 2000 through a merger of Glaxo Wellcome and SmithKline Beecham. The company focuses on the development of prescription medicines, vaccines, and consumer healthcare products. Their drug portfolio includes treatments for a wide range of diseases, including respiratory, HIV, oncology, and infectious diseases. They also have a strong presence in the development of vaccines and healthcare products. Overall, GlaxoSmithKline is known for its extensive research and development efforts in the healthcare sector.
Description
Grifols is a pharmaceutical company founded in 1940. The company is primarily focused on the development and manufacturing of plasma-derived therapies, vaccines, and hospital pharmacy products. Grifols has been particularly active in the treatment of rare and chronic diseases such as immune deficiencies, genetic emphysema, and other conditions related to the immune system. They also offer a variety of diagnostic products and services for the healthcare industry.
Drugs of Grifols
Description
Huya Bioscience is a global pharmaceutical company founded in 2004. They focus on discovering, developing, and commercializing innovative medications for the treatment of various diseases, with a particular emphasis on oncology and neurodegenerative disorders. They have a robust pipeline of drugs aimed at addressing unmet medical needs in these therapeutic areas. Their dedication to scientific research and development has led to the creation of novel treatments with the potential to significantly impact patient care.
Drugs of Huya Bioscience
Description
INO Therapeutics LLC is a pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of respiratory and cardiovascular diseases. Their main drug, INOmax (nitric oxide), is used to treat infants with hypoxic respiratory failure and has been proven effective in improving oxygenation and reducing the need for extracorporeal membrane oxygenation (ECMO). The company was founded in 1995 and is known for its expertise in inhaled nitric oxide therapy.
Drugs of INO Therapeutics LLC
Drugs of Inc.
Description
Incyte is a pharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. They have a particular focus on oncology and have developed drugs for the treatment of various cancers, including myeloproliferative neoplasms, advanced malignancies, and graft-versus-host disease. The company was founded in 1991 and has been actively involved in research and development in the areas of immuno-oncology and targeted therapies.
Drugs of Incyte
Description
JCR Pharmaceuticals is a Japanese bio-pharmaceutical company specializing in the development of innovative therapeutic agents. The company focuses on the research and development of biopharmaceutical products for the treatment of genetic and immune-related diseases. Since its founding in 1977, JCR Pharmaceuticals has been dedicated to the development of cutting-edge drugs and technologies for various medical conditions, including familial hypercholesterolemia and Pompe disease. JCR Pharmaceuticals also engages in collaborative research and licensing activities to expand its product pipeline.
Description
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is a pharmaceutical company founded in 1953. The company focuses on the research and development of innovative drugs and treatments for a wide range of diseases, including cancer, mental health disorders, infectious diseases, and autoimmune disorders. Some of their notable drugs include Remicade, Invokana, and Xarelto, which are used in the treatment of autoimmune disorders, diabetes, and cardiovascular conditions, respectively. Janssen Pharmaceuticals is known for its commitment to scientific advancement and improving patient outcomes.
Description
Japan Tobacco is a global pharmaceutical company that focuses on the development and production of a wide range of drugs. Their primary emphasis is on treatments for diseases such as cancer, autoimmune disorders, cardiovascular diseases, and respiratory diseases. The company was established in 1999 and has since dedicated substantial resources to research and development in the pharmaceutical field. Please note that Japan Tobacco also has a major focus on tobacco products in addition to pharmaceuticals.
Description
Johnson & Johnson, founded in 1886, is a global healthcare company focusing on consumer health, pharmaceuticals, and medical devices. The company develops and markets a wide range of drugs to treat various diseases and conditions, including cardiovascular and metabolic diseases, immunology, oncology, neuroscience, and infectious diseases. Some of their notable drugs include Remicade, Invokana, and Stelara. Additionally, Johnson & Johnson has been involved in the development and production of vaccines and has a strong focus on research and development in the healthcare field.
Drugs of Johnson & Johnson
Description
Kaken Pharmaceutical is a Japanese pharmaceutical company founded in 1947. The company focuses on the research, development, and commercialization of pharmaceutical products primarily in the therapeutic areas of dermatology, pain management, and ophthalmology. Some of their key drugs include anti-infective agents, antifungals, anti-inflammatory agents, and migraine treatments. Kaken Pharmaceutical has a strong presence in the Japanese pharmaceutical market and continues to expand its reach globally.
Description
Kaneka Corporation is a pharmaceutical company with a focus on developing and producing pharmaceuticals, including drugs for various diseases and medical conditions. Founded in 1949, the company has been involved in the development of medications for cardiovascular diseases, metabolic disorders, and other therapeutic areas. Additionally, the company has research and development initiatives in biotechnology and medical devices.
Drugs of Kaneka Corporation
Description
Kissei Pharmaceutical is a Japan-based company founded in 1946, with a focus on research and development of pharmaceuticals. The company specializes in drugs for conditions such as urological disorders, ophthalmological diseases, and nephrological diseases. Some of their key drugs include Tamsulosin hydrochloride for the treatment of benign prostatic hyperplasia, and Dorzolamide hydrochloride for glaucoma. Their commitment to scientific research and development has made them a prominent player in the pharmaceutical industry.
Drugs of Kissei Pharmaceutical
Description
The Kitasato Institute is a scientific research organization based in Tokyo, Japan. Founded in 1914, the institute focuses on medical and pharmaceutical research, with an emphasis on infectious diseases, immunology, and vaccine development. They have contributed significantly to the field of microbiology and have been involved in the development of vaccines and treatments for various infectious diseases. Additionally, the Kitasato Institute conducts research on a range of pharmaceutical products and therapies for conditions such as tuberculosis, influenza, and other infectious diseases.
Drugs of Kitasato Institute
Drugs of Kowa
Description
Kyorin Pharmaceutical is a Japanese pharmaceutical company that focuses on the research, development, and manufacturing of pharmaceutical products. The company was founded in 1947 and has a strong focus on respiratory and infectious diseases. Kyorin Pharmaceutical has developed drugs to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and infectious diseases. Their commitment to scientific advancement is evident in their efforts to develop innovative treatments that address unmet medical needs in the respiratory and infectious disease fields.
Drugs of Kyorin Pharmaceutical
Description
Kyowa Kirin is a pharmaceutical company that specializes in the development and commercialization of innovative biopharmaceuticals. The company focuses on the areas of oncology, nephrology, and rare diseases. They have a strong research and development pipeline, with a particular emphasis on biologics and other advanced therapies. Kyowa Kirin also has a range of drugs targeting various diseases such as multiple myeloma, renal cell carcinoma, and certain rare genetic disorders. The company was founded in 1949 and continues to be a leader in the field of biopharmaceutical research and development.
Description
MSD, also known as Merck & Co., Inc., is a global pharmaceutical company that was founded in 1891. The company is known for its focus on discovering, developing, and providing a wide range of medications and vaccines to address various diseases and medical conditions. MSD's research areas include oncology, infectious diseases, cardiovascular diseases, diabetes, respiratory disorders, and more. The company has developed and marketed numerous drugs and vaccines for the treatment and prevention of diseases such as cancer, HIV/AIDS, hepatitis, diabetes, and many others.
Description
Mallinckrodt is a pharmaceutical company specializing in the development and commercialization of specialty pharmaceuticals and imaging agents. The company is focused on therapeutic areas such as autoimmune and rare diseases, pain management, and central nervous system disorders. Founded in 1867, Mallinckrodt is known for its portfolio of branded and generic drugs that target a variety of medical conditions and diseases.
Drugs of Mallinckrodt
Description
Maruho is a Japanese pharmaceutical company that specializes in dermatology. Founded in 1915, the company has a focus on developing and producing dermatologic drugs and treatments for various skin conditions such as atopic dermatitis, psoriasis, acne, and other inflammatory skin disorders. Some of their key products include topical steroids, immunomodulators, and skincare products. Maruho is dedicated to advancing the field of dermatology by conducting research and clinical trials to bring innovative treatments to patients worldwide.
Description
Maruishi Pharmaceutical is a Japanese company that specializes in developing and producing pharmaceutical products primarily focused on treating various diseases such as neurological disorders, autoimmune diseases, and infectious diseases. The company was founded in 1957, and it has a strong focus on research and development to bring innovative and effective drugs to the market. Some of their key drugs may include treatments for conditions like multiple sclerosis, rheumatoid arthritis, and infectious diseases.
Description
Meiji Seika Pharma Co., Ltd. is a Japanese pharmaceutical company that was founded in 1885. The company has a focus on research and development of drugs for a wide range of therapeutic areas including infectious diseases, diabetes, cancer, and metabolic disorders. Their portfolio includes medications for the treatment of various conditions, and they have a strong commitment to innovation and improving patient care.
Drugs of Meiji Seika
Description
Meiji Seika Pharma is a pharmaceutical company founded in 1931 in Japan. The company focuses on the research, development, and commercialization of pharmaceutical products with a particular emphasis on treatments for neurological disorders, infectious diseases, and metabolic diseases. Their portfolio includes drugs for the treatment of conditions such as diabetes, Alzheimer's disease, and various infectious diseases. Meiji Seika Pharma is committed to advancing scientific knowledge and improving healthcare outcomes through its innovative drug therapies.
Drugs of Meiji Seika Pharma
Description
Merck Biopharma, a division of Merck & Co., is a research-focused pharmaceutical company that works in the areas of oncology, immunology, and neurology. The company's drugs are used to treat a wide range of diseases and conditions, including cancer, autoimmune disorders, infectious diseases, and cardiovascular diseases. Merck Biopharma is known for its emphasis on cutting-edge research and development in biopharmaceuticals, and it is committed to advancing treatments and therapies that improve patients' lives. Unfortunately, specific founding year information is not available.
Drugs of Minophagen Pharmaceutical
Description
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company established in 1678 and has a strong focus on the research and development of innovative drugs for the treatment of neurological and autoimmune diseases. The company is known for its expertise in areas such as multiple sclerosis, amyotrophic lateral sclerosis (ALS), and rheumatoid arthritis. Mitsubishi Tanabe Pharma is committed to advancing scientific knowledge and developing effective therapeutic options for patients worldwide.
Drugs of Mitsubishi Tanabe Pharma
Description
Mochida Pharmaceutical is a Japanese pharmaceutical company that was founded in 1933. They focus on developing and producing a wide range of pharmaceutical products, including drugs for various therapeutic areas such as central nervous system disorders, cardiovascular diseases, and gastrointestinal disorders. They also have a focus on research and development of new drugs for the treatment of cancer, diabetes, and rare diseases. Mochida Pharmaceutical is committed to contributing to the health and well-being of people by providing innovative and effective treatment options.
Description
Mundipharma is a global pharmaceutical company that focuses on developing and manufacturing a wide range of pharmaceutical products. They have a particular emphasis on pain management, cancer support, and respiratory health. The company was founded in 1952 and has built a strong reputation in the research and development of innovative medicines to address various diseases and conditions. Their portfolio includes drugs for pain relief, oncology treatments, and respiratory therapies.
Description
Mylan is a global pharmaceutical company that specializes in developing and marketing a wide range of generic and branded pharmaceutical products. Founded in 1961, Mylan focuses on providing affordable access to high-quality medicine for patients worldwide, with a particular emphasis on products for the treatment of respiratory, central nervous system, dermatological, and other therapeutic areas. The company is also involved in the development and distribution of biosimilar and complex generic products. Mylan's portfolio includes medications for managing chronic diseases such as asthma, epilepsy, multiple sclerosis, and HIV, as well as a variety of other therapeutic areas.
Drugs of Mylan
Drugs of Nagase ChemteX
Description
Nihon Medi-Physics is a pharmaceutical company based in Japan. They specialize in the development and manufacturing of radiopharmaceuticals for diagnostic imaging and treatment of various diseases, including cancer and neurological disorders. The company was founded in 1960 and has since focused on the research and production of innovative drugs and medical solutions for the advancement of nuclear medicine.
Drugs of Nihon Medi-Physics
Description
Nippon Kayaku is a pharmaceutical company founded in 1916, with a focus on developing and manufacturing a wide range of drugs and pharmaceutical products. The company's portfolio includes medications for the treatment of various diseases, with a particular emphasis on oncology, ophthalmology, and inflammatory disorders. Nippon Kayaku is known for its commitment to research and development, aiming to bring innovative therapies to patients in need.
Drugs of Nippon Kayaku
Description
Nippon Nohyaku is a Japanese pharmaceutical company that specializes in the development and production of agrochemicals, pharmaceuticals, and veterinary products. Founded in 1936, the company has a strong focus on research and development in the agricultural and healthcare sectors. Their pharmaceutical products primarily focus on the treatment and prevention of diseases in animals. Unfortunately, specific drugs and diseases treated by the company were not readily available.
Drugs of Nippon Nohyaku
Description
Nippon Shinyaku is a pharmaceutical company that was founded in 1919 in Kyoto, Japan. The company focuses on research and development in the areas of prescription drugs, over-the-counter medications, and active pharmaceutical ingredients. They have a strong focus on cardiovascular, central nervous system, and infectious diseases. Nippon Shinyaku is known for developing drugs to treat conditions such as hypertension, arrhythmia, and pain management. Their commitment to scientific advancement and innovation has made them a significant player in the pharmaceutical industry.
Description
Nipro Corporation is a global pharmaceutical company founded in 1954. It is known for its focus on medical devices and pharmaceutical products, particularly in the fields of nephrology, cardiology, and urology. The company's products include drug delivery systems, dialysis equipment, and medical devices for various medical conditions. Nipro Corporation has a strong presence in the treatment of kidney disease, cardiovascular conditions, and urological disorders.
Description
Nissan Chemical Industries is a pharmaceutical company that was founded in 1887 in Japan. The company specializes in the research, development, and manufacturing of pharmaceuticals and fine chemicals. They have a focus on developing drugs for the treatment of various diseases, including cancer, cardiovascular disease, and central nervous system disorders. They have a reputation for producing high-quality pharmaceuticals and are known for their contributions to the advancement of medical science.
Drugs of Nissan Chemical Industries
Description
Novartis is a pharmaceutical company with a focus on developing and manufacturing innovative medicines, particularly in the areas of oncology, cardiovascular, and respiratory diseases, as well as neuroscience. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has a strong global presence and has developed a wide range of drugs for the treatment of various diseases, including cancer, multiple sclerosis, diabetes, and other serious medical conditions.
Description
Novo Nordisk is a pharmaceutical company founded in 1923, specializing in diabetes care, hemophilia, growth disorders, and obesity. They are known for their development of insulin products and other medications for the treatment of chronic diseases. The company focuses on research and innovation to improve outcomes for patients with these conditions.
Description
Ohara Pharmaceutical is a Japan-based pharmaceutical company that was founded in 1952. The company focuses on the research, development, and production of pharmaceutical products, including drugs for various therapeutic areas such as digestive diseases, cardiovascular disorders, and central nervous system disorders. Their portfolio includes medications for conditions such as peptic ulcers, hypertension, and psychiatric disorders. Additionally, the company has a strong focus on innovative drug development and is committed to improving patient outcomes through their research and product development efforts.
Description
Ono Pharmaceutical is a Japanese pharmaceutical company that was founded in 1717. The company focuses on the research and development of innovative pharmaceutical products in the fields of oncology, immunology, neurology, and metabolic diseases. They have developed drugs for the treatment of cancer, multiple sclerosis, rheumatoid arthritis, and diabetes among other conditions. Ono Pharmaceutical is known for its commitment to advancing medical science and improving patient outcomes.
Description
Organon is a pharmaceutical company that was founded in 1923 and has a strong focus on developing drugs for women's health, particularly in the areas of reproductive health, fertility, and hormone-related disorders. They have developed several drugs to treat conditions such as menopausal symptoms, contraception, and hormone replacement therapy. Their research and development efforts also extend to areas such as neuroscience, oncology, and rare diseases.
Description
Otsuka Pharmaceutical is a global healthcare company that develops and markets innovative pharmaceutical products and solutions for the treatment of a wide range of diseases. The company was founded in 1921 and is known for its focus on research and development in the areas of mental health, cardiovascular health, oncology, and nephrology. Otsuka Pharmaceutical has a diverse portfolio of drugs, including products for the treatment of mental disorders such as schizophrenia and bipolar disorder, as well as solutions for cardiovascular diseases and cancer.
Drugs of Otsuka Pharmaceutical
Description
Pfizer is a leading pharmaceutical company founded in 1849. It is known for its expertise in developing drugs for a wide range of diseases and conditions, including cardiovascular diseases, infectious diseases, cancer, and rare diseases. The company's focus also includes immunology, inflammation, and neurology. Pfizer has developed several well-known and widely prescribed medications, such as Lipitor for cholesterol management, Viagra for erectile dysfunction, and Enbrel for autoimmune diseases.
Drugs of Pola Chemical Industries
Description
Rakuten Medical is a pharmaceutical company specializing in developing innovative cancer therapies. Their focus is on using their proprietary platform technology to create drugs that target cancer cells while sparing healthy cells. The company's lead drug, ASP-1929, is being studied for the treatment of various types of solid tumors, including head and neck cancer. Rakuten Medical was founded in 2008 and has since been dedicated to advancing the field of cancer therapy with a scientific and patient-centered approach.
Drugs of Rakuten Medical
Description
Recordati Rare Diseases is a pharmaceutical company that focuses on developing and marketing treatments for rare diseases. The company's portfolio includes a range of therapeutic options for conditions such as Wilson's disease, nephropathic cystinosis, and a variety of inborn errors of metabolism. Founded in 1926, the company has a long history of commitment to addressing unmet medical needs in the rare disease space. Their research and development efforts are centered on providing innovative therapies to improve the lives of patients with rare diseases.
Drugs of Recordati Rare Diseases
Description
ReqMed is a pharmaceutical company that was founded in 2010 and focuses on the development and commercialization of drugs for the treatment of autoimmune diseases. They have a strong focus on developing biologic drugs targeting specific molecular pathways involved in inflammatory and autoimmune disorders. ReqMed's portfolio includes drugs for rheumatoid arthritis, psoriasis, multiple sclerosis, and other related conditions. Their research and development efforts are centered on advancing innovative treatment options for patients with these diseases.
Drugs of ReqMed
Description
SBI Pharmaceuticals is a company focused on the development of innovative pharmaceutical products, particularly in the field of regenerative medicine and biotechnology. The company was founded in 2004 and has since been involved in the development of drugs to treat various diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions. SBI Pharmaceuticals has a strong focus on research and development, aiming to bring new and effective treatments to patients in need.
Drugs of SBI Pharmaceuticals
Description
Sanofi is a multinational pharmaceutical company with a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products. Founded in 1973, Sanofi focuses on areas such as diabetes, cardiovascular diseases, rare diseases, multiple sclerosis, oncology, and vaccines. Some of their notable drugs include Lantus (insulin glargine) for diabetes, Dupixent (dupilumab) for atopic dermatitis and asthma, and Aubagio (teriflunomide) for multiple sclerosis. They are dedicated to advancing healthcare and improving the lives of patients around the world.
Description
Santen Pharmaceutical is a global pharmaceutical company specializing in ophthalmology. The company was founded in 1890 in Japan and has since developed a range of innovative drugs and therapies for the treatment of various eye diseases and disorders. Their focus areas include the development of pharmaceuticals, medical devices, and over-the-counter products for the treatment of conditions such as glaucoma, dry eye syndrome, uveitis, and retinal diseases. Santen Pharmaceutical is committed to advancing ophthalmic research and addressing unmet medical needs in the field of eye care.
Drugs of Santen Pharmaceutical
Drugs of Sanwa Kagaku Kenkyusho
Description
Sato Pharmaceutical is a leading Japanese pharmaceutical company founded in 1915. The company focuses on the development and manufacturing of a wide range of pharmaceutical products, including over-the-counter medicines, medical devices, and consumer healthcare products. Sato Pharmaceutical's primary focus areas include gastroenterology, dermatology, and pain management. They have a strong portfolio of drugs and treatments for various conditions, such as gastrointestinal disorders, skin diseases, and pain management.
Description
I'm unable to find information on a pharmaceutical company named Seikagaku. It's possible that it may not be widely known in scientific literature or other reputable sources.
Drugs of Seikagaku
Description
Senju Pharmaceutical is a Japanese pharmaceutical company that focuses on the development and manufacturing of drugs related to ophthalmology. The company is known for its research and production of pharmaceutical products aimed at treating eye diseases and disorders. Senju Pharmaceutical has a strong emphasis on developing innovative solutions for conditions such as glaucoma, dry eye, and other ophthalmic diseases. The company was founded in 1940 and continues to be a leading player in the field of ophthalmic pharmaceuticals.
Drugs of Shiono Finesse
Description
I'm unable to find information on a pharmaceutical company named Shiono Koryo. It's possible that this company may not be widely recognized or may not have a significant presence in the available scientific literature. If you have any other specific pharmaceutical companies in mind, I'd be happy to provide information on those.
Drugs of Shiono Koryo
Description
Shionogi is a global pharmaceutical company founded in 1878 in Osaka, Japan. The company focuses on research and development in the areas of infectious diseases, pain management, metabolic syndrome, and cancer. Shionogi is known for developing innovative drugs to treat HIV, influenza, and other infectious diseases. They also have a strong presence in the field of pain management, developing medications to address acute and chronic pain. Overall, Shionogi is dedicated to advancing medical science and improving the lives of patients through its pharmaceutical products.
Drugs of Solvay Seiyaku
Drugs of Stella Pharma
Description
Sumitomo Dainippon Pharma is a pharmaceutical company based in Japan. Founded in 2005, the company focuses on research and development of drugs for a wide range of therapeutic areas including central nervous system disorders, oncology, and infectious diseases. They have developed medications for the treatment of conditions such as schizophrenia, depression, bipolar disorder, and Parkinson's disease, among others. Additionally, Sumitomo Dainippon Pharma is also involved in the development of novel therapies for cancer and infectious diseases.
Drugs of Sumitomo Dainippon Pharma
Description
Sun Pharma is a multinational pharmaceutical company founded in 1983. The company focuses on developing and producing active pharmaceutical ingredients and finished dosage forms. Their portfolio includes drugs for a wide range of therapeutic areas such as dermatology, neurology, cardiology, ophthalmology, oncology, and psychiatry. Some of their notable drugs include Abilify, Xalatan, and Glumetza. Additionally, Sun Pharma is involved in the development of generic drugs and has a strong global presence, particularly in the United States and other key markets.
Description
SymBio Pharmaceuticals is a pharmaceutical company known for its focus on developing treatments for rare diseases and cancers. The company was founded in 2005 and has a strong emphasis on research and development in oncology and hematology. SymBio Pharmaceuticals has developed drugs for various indications, including therapies for malignant lymphoma, leukemia, and solid tumors. They are committed to creating innovative and effective treatments for patients with unmet medical needs.
Drugs of SymBio Pharmaceuticals
Description
Taiho Pharmaceutical is a Japanese research-based pharmaceutical company with a focus on oncology. It was founded in 1963 and has since developed a range of drugs for the treatment of various cancers, including colorectal, gastric, pancreatic, and lung cancers. Taiho Pharmaceutical is known for its expertise in developing innovative cancer therapies and remains committed to improving patient outcomes through scientific advancements in the field of oncology.
Description
Taisho Pharmaceutical is a Japanese pharmaceutical company that was founded in 1912. The company's focus areas include developing and manufacturing a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and health-related products. Taisho Pharmaceutical has a strong presence in several therapeutic areas, such as gastrointestinal, mental health, and women's health. They are known for their contributions to the development of treatments for various diseases and health conditions, including acid-related diseases, mental health disorders, and women's health issues.
Drugs of Taisho Pharmaceutical
Description
Takeda Pharmaceutical Company is a global pharmaceutical company with a strong focus on research and development. It was founded in 1781 in Osaka, Japan, making it one of the oldest pharmaceutical companies in the world. Takeda has a diverse portfolio of drugs that treat a variety of conditions, including gastrointestinal diseases, central nervous system disorders, cardiovascular diseases, and oncology. They have established a strong presence in the fields of gastroenterology, oncology, and neuroscience. Their commitment to innovation and collaboration has allowed them to bring numerous important drugs to market, addressing the needs of patients worldwide.
Description
Teijin Pharma is a Japanese pharmaceutical company that focuses on research, development, manufacturing, and marketing of pharmaceutical products. They develop drugs primarily in the areas of respiratory diseases, bone and joint diseases, and circulatory diseases. Founded in 1940, Teijin Pharma has a strong focus on improving patient outcomes through the development of innovative and effective treatments for various medical conditions. Some of their key therapeutic areas include asthma, chronic obstructive pulmonary disease (COPD), and osteoporosis.
Drugs of Teijin Pharma
Description
Teikoku Seiyaku is a pharmaceutical company based in Japan and was founded in 1940. The company has a focus on research and development in the pharmaceutical and healthcare fields. They are known for their development and manufacturing of transdermal patches and various drug delivery systems. Teikoku Seiyaku has developed medications for different therapeutic areas, including pain management, neurological disorders, and other conditions. They have a strong emphasis on innovation in drug delivery methods to improve patient outcomes.
Description
Terumo Corporation is a leading global medical technology company founded in 1921, specializing in the design, development, and manufacturing of medical devices. Their focus areas include cardiovascular and peripheral vascular interventions, oncology, and other therapeutic areas. They provide a range of products used in the treatment of various diseases including cardiovascular diseases, cancer, and other medical conditions. Terumo's commitment to innovation and research has led to the development of advanced medical devices and technologies aimed at improving patient care and outcomes.
Drugs of Terumo Corporation
Drugs of Toko Pharmaceutical Industrial
Drugs of Toray Medical
Description
Torii Pharmaceutical is a Japanese company that specializes in the research, development, and manufacturing of pharmaceutical products. They focus on a wide range of therapeutic areas including cardiovascular, respiratory, and neurology. The company has a strong portfolio of drugs for treating conditions such as hypertension, asthma, and epilepsy. Torii Pharmaceutical was founded in 1921 and has a long history of contributing to the advancement of medical science and improving patient outcomes.
Drugs of Torii Pharmaceutical
Drugs of Tosoh Akzo
Description
UCB is a multinational biopharmaceutical company specializing in neurological and immunological diseases. The company was founded in 1928 and focuses on developing therapies for epilepsy, Parkinson's disease, Crohn's disease, and rheumatoid arthritis, among other conditions. UCB has a varied portfolio of drugs, including Keppra for epilepsy and Cimzia for rheumatoid arthritis and Crohn's disease.
Description
Ube Industries is a prominent pharmaceutical company. The company was founded in 1897 and is well-known for its focus on developing innovative drugs to treat a wide range of diseases and medical conditions. Ube Industries is involved in the research and development of pharmaceutical products for various therapeutic areas, including but not limited to oncology, neurology, cardiology, and infectious diseases. Their portfolio includes drugs for the treatment of cancer, cardiovascular diseases, central nervous system disorders, and infectious diseases, among others. The company is committed to advancing medical science and providing effective treatment options for patients worldwide.
Description
Viiv Healthcare is a pharmaceutical company specializing in HIV/AIDS research and treatment. Founded in 2009, the company focuses on developing innovative drugs and therapies for the treatment and management of HIV, including antiretroviral medications. Viiv Healthcare's commitment to addressing the complex challenges of HIV/AIDS has led to the introduction of several important medications for preventing and treating the disease.
Drugs of Viiv Healthcare
Description
Wakamoto Pharma is a pharmaceutical company founded in 1929, focusing on the research and development of drugs for a range of therapeutic areas. They have a strong presence in developing medications for cardiovascular diseases, infectious diseases, central nervous system disorders, and gastrointestinal conditions. Their portfolio includes a variety of drugs designed to treat hypertension, diabetes, influenza, depression, and gastrointestinal disorders. The company continues to prioritize scientific innovation in drug development and places a significant emphasis on patient care and well-being.
Drugs of Wakamoto Pharma
Description
Wellcome was a pharmaceutical company known for its focus on developing drugs for the treatment of various diseases. The company was founded in 1880 and had a strong emphasis on research and development in the areas of infectious diseases, neuroscience, and immunology. Wellcome developed several important drugs for conditions such as malaria, HIV/AIDS, and neurological disorders, making significant contributions to the field of medicine.
Drugs of Wellcome
Drugs of Yakult Pharmaceutical
Drugs of Yuki Gosei Kogyo
Description
I'm unable to find specific scientific information about the pharmaceutical company "Zenyaku Kogyo." Therefore, I am unable to provide a description at this time. If you have any other questions, feel free to ask!
Description
Zeria Pharmaceutical is a Japanese pharmaceutical company founded in 1955. The company is primarily focused on the research, development, and marketing of pharmaceutical products for the treatment of gastrointestinal, respiratory, and dermatological diseases. They have a range of drugs targeting conditions such as acid-related diseases, respiratory tract infections, and skin disorders. Zeria Pharmaceutical is committed to advancing medical treatments for these areas of focus and contributing to improvements in healthcare.